{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:10:59Z","timestamp":1792757459473,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18ck0106194"],"award-info":[{"award-number":["JP18ck0106194"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Interactive networks of transcription factors (TFs) have critical roles in epigenetic and gene regulation for cancer progression. It is required to clarify underlying mechanisms for transcriptional activation through concerted efforts of TFs. Here, we show the essential role of disease phase-specific TF collaboration changes in advanced prostate cancer (PC). Investigation of the transcriptome in castration-resistant PC (CRPC) revealed OCT4 as a key TF in the disease pathology. OCT4 confers epigenetic changes by promoting complex formation with FOXA1 and androgen receptor (AR), the central signals for the progression to CRPC. Meanwhile, OCT4 facilitates a distinctive complex formation with nuclear respiratory factor 1 (NRF1) to gain chemo-resistance in the absence of AR. Mechanistically, we reveal that OCT4 increases large droplet formations with AR\/FOXA1 as well as NRF1 in vitro. Disruption of TF collaborations using a nucleoside analogue, ribavirin, inhibited treatment-resistant PC tumor growth. Thus, our findings highlight the formation of TF collaborations as a potent therapeutic target in advanced cancer.<\/jats:p>","DOI":"10.1038\/s41467-021-23974-4","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T10:03:33Z","timestamp":1624010613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Subtype-specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2832-1434","authenticated-orcid":false,"given":"Ken-ichi","family":"Takayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4371-4594","authenticated-orcid":false,"given":"Takeo","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0195-815X","authenticated-orcid":false,"given":"Takashi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mototsugu","family":"Oya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4852-1879","authenticated-orcid":false,"given":"Yutaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1247-3844","authenticated-orcid":false,"given":"Satoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"23974_CR1","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2018.05.036","volume":"174","author":"SR Viswanathan","year":"2018","unstructured":"Viswanathan, S. R. et al. Structural alterations driving castration-resistant prostate cancer revealed by linked-read genome sequencing. Cell 174, 433\u2013447 (2018).","journal-title":"Cell"},{"key":"23974_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature11125","volume":"487","author":"CS Grasso","year":"2012","unstructured":"Grasso, C. S. et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239\u2013243 (2012).","journal-title":"Nature"},{"key":"23974_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nm972","volume":"10","author":"CD Chen","year":"2004","unstructured":"Chen, C. D. et al. Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 10, 33\u201339 (2004).","journal-title":"Nat. Med."},{"key":"23974_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrurol.2018.22","volume":"15","author":"AH Davies","year":"2018","unstructured":"Davies, A. H., Beltran, H. & Zoubeidi, A. Cellular plasticity and the neuroendocrine phenotype in prostate cancer. Nat. Rev. Urol. 15, 271\u2013286 (2018).","journal-title":"Nat. Rev. Urol."},{"key":"23974_CR5","doi-asserted-by":"publisher","first-page":"10461","DOI":"10.1073\/pnas.1706076114","volume":"114","author":"K Takayama","year":"2017","unstructured":"Takayama, K. et al. Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF. Proc. Natl Acad. Sci. USA 114, 10461\u201310466 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"23974_CR6","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.cell.2008.01.018","volume":"132","author":"M Lupien","year":"2008","unstructured":"Lupien, M. et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132, 958\u2013970 (2008).","journal-title":"Cell"},{"key":"23974_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ccr.2012.11.010","volume":"23","author":"NL Sharma","year":"2013","unstructured":"Sharma, N. L. et al. The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man. Cancer Cell 23, 35\u201347 (2013).","journal-title":"Cancer Cell"},{"key":"23974_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ccell.2014.11.013","volume":"27","author":"SJ Vidal","year":"2015","unstructured":"Vidal, S. J. et al. A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer. Cancer Cell 27, 223\u2013239 (2015).","journal-title":"Cancer Cell"},{"key":"23974_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cell.2009.04.056","volume":"138","author":"Q Wang","year":"2009","unstructured":"Wang, Q. et al. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 138, 245\u2013256 (2009).","journal-title":"Cell"},{"key":"23974_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.cell.2008.04.043","volume":"133","author":"X Chen","year":"2008","unstructured":"Chen, X. et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133, 1106\u20131117 (2008).","journal-title":"Cell"},{"key":"23974_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.molcel.2007.05.041","volume":"27","author":"Q Wang","year":"2007","unstructured":"Wang, Q. et al. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol. Cell 27, 380\u2013392 (2007).","journal-title":"Mol. Cell"},{"key":"23974_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4972","volume":"5","author":"HJ Jin","year":"2014","unstructured":"Jin, H. J., Zhao, J. C., Wu, L., Kim, J. & Yu, J. Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program. Nat. Commun. 5, 3972 (2014).","journal-title":"Nat. Commun."},{"key":"23974_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ccell.2016.09.005","volume":"30","author":"E Dardenne","year":"2016","unstructured":"Dardenne, E. et al. N-Myc induces an EZH2-mediated transcriptional program driving neuroendocrine prostate cancer. Cancer Cell 30, 563\u2013577 (2016).","journal-title":"Cancer Cell"},{"key":"23974_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.aah4307","volume":"355","author":"P Mu","year":"2017","unstructured":"Mu, P. et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science 355, 84\u201388 (2017).","journal-title":"Science"},{"key":"23974_CR15","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/s41591-018-0241-1","volume":"24","author":"M Rotinen","year":"2018","unstructured":"Rotinen, M. et al. ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis. Nat. Med. 24, 1887\u20131898 (2018).","journal-title":"Nat. Med."},{"key":"23974_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08133-6","volume":"10","author":"H Guo","year":"2019","unstructured":"Guo, H. et al. ONECUT2 is a driver of neuroendocrine prostate cancer. Nat. Commun. 10, 278 (2019).","journal-title":"Nat. Commun."},{"key":"23974_CR17","doi-asserted-by":"publisher","first-page":"R1097","DOI":"10.1016\/j.cub.2017.08.069","volume":"27","author":"S Alberti","year":"2017","unstructured":"Alberti, S. Phase separation in biology. Curr. Biol. 27, R1097\u2013R1102 (2017).","journal-title":"Curr. Biol."},{"key":"23974_CR18","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.cell.2018.10.042","volume":"175","author":"A Boija","year":"2018","unstructured":"Boija, A. et al. Factors activate genes through the phase separation capacity of their activation domains. Cell 175, 1842\u20131855 (2018). e16.","journal-title":"Cell"},{"key":"23974_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrm.2017.7","volume":"18","author":"SF Banani","year":"2017","unstructured":"Banani, S. F., Lee, H. O., Hyman, A. A. & Rosen, M. K. Biomolecular condensates: organizers of cellular biochemistry. Nat. Rev. Mol. Cell Biol. 18, 285\u2013298 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"23974_CR20","doi-asserted-by":"publisher","first-page":"eaaf4382","DOI":"10.1126\/science.aaf4382","volume":"357","author":"Y Shin","year":"2017","unstructured":"Shin, Y. & Brangwynne, C. P. Liquid phase condensation in cell physiology and disease. Science 357, eaaf4382 (2017).","journal-title":"Science"},{"key":"23974_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nrm3920","volume":"16","author":"PE Wright","year":"2015","unstructured":"Wright, P. E. & Dyson, H. J. Intrinsically disordered proteins in cellular signalling and regulation. Nat. Rev. Mol. Cell Biol. 16, 18\u201329 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"23974_CR22","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.molcel.2015.01.013","volume":"57","author":"TJ Nott","year":"2015","unstructured":"Nott, T. J. et al. Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles. Mol. Cell 57, 936\u2013947 (2015).","journal-title":"Mol. Cell"},{"key":"23974_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41594-019-0190-5","volume":"26","author":"SJ Nair","year":"2019","unstructured":"Nair, S. J. et al. Phase separation of ligand-activated enhancers licenses cooperative chromosomal enhancer assembly. Nat. Struct. Mol. Biol. 26, 193\u2013203 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"23974_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cell.2017.02.007","volume":"169","author":"D Hnisz","year":"2017","unstructured":"Hnisz, D., Shrinivas, K., Young, R. A., Chakraborty, A. K. & Sharp, P. A. A phase separation model for transcriptional control. Cell 169, 13\u201323 (2017).","journal-title":"Cell"},{"key":"23974_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41586-019-1464-0","volume":"572","author":"YE Guo","year":"2019","unstructured":"Guo, Y. E. et al. Pol II phosphorylation regulates a switch between transcriptional and splicing condensates. Nature 572, 543\u2013548 (2019).","journal-title":"Nature"},{"key":"23974_CR26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"23974_CR27","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1128\/MCB.19.4.2635","volume":"19","author":"A Brehm","year":"1999","unstructured":"Brehm, A. et al. Synergism with germ line transcription factor Oct-4: viral oncoproteins share the ability to mimic a stem cell-specific activity. Mol. Cell Biol. 19, 2635\u20132643 (1999).","journal-title":"Mol. Cell Biol."},{"key":"23974_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s42003-020-01120-y","volume":"3","author":"K Takayama","year":"2020","unstructured":"Takayama, K., Fujimura, T., Suzuki, Y. & Inoue, S. Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors. Commun. Biol. 3, 393 (2020).","journal-title":"Commun. Biol."},{"key":"23974_CR29","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ccr.2014.03.017","volume":"25","author":"A Aytes","year":"2014","unstructured":"Aytes, A. et al. Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy. Cancer Cell 25, 638\u2013651 (2014).","journal-title":"Cancer Cell"},{"key":"23974_CR30","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/cas.12183","volume":"104","author":"T Kosaka","year":"2013","unstructured":"Kosaka, T. et al. Identification of drug candidate against prostate cancer from the aspect of somatic cell reprogramming. Cancer Sci. 104, 1017\u20131026 (2013).","journal-title":"Cancer Sci."},{"key":"23974_CR31","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2011","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2011).","journal-title":"Mol. Cell"},{"key":"23974_CR32","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz, D. et al. Super-enhancers in the control of cell identity and disease. Cell 155, 934\u2013947 (2013).","journal-title":"Cell"},{"key":"23974_CR33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WarrenA Whyte","year":"2013","unstructured":"Whyte, W. A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307\u2013319 (2013).","journal-title":"Cell"},{"key":"23974_CR34","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0959-437X(95)80007-7","volume":"5","author":"SJ Triezenberg","year":"1995","unstructured":"Triezenberg, S. J. Structure and function of transcriptional activation domains. Curr. Opin. Genet Dev. 5, 190\u2013196 (1995).","journal-title":"Curr. Opin. Genet Dev."},{"key":"23974_CR35","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cell.2012.04.017","volume":"149","author":"M Kato","year":"2012","unstructured":"Kato, M. et al. Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell 149, 753\u2013767 (2012).","journal-title":"Cell"},{"key":"23974_CR36","doi-asserted-by":"publisher","first-page":"eaar3958","DOI":"10.1126\/science.aar3958","volume":"361","author":"BR Sabari","year":"2018","unstructured":"Sabari, B. R. et al. Coactivator condensation at super-enhancers links phase separation and gene control. Science 361, eaar3958 (2018).","journal-title":"Science"},{"key":"23974_CR37","doi-asserted-by":"publisher","first-page":"e06807","DOI":"10.7554\/eLife.06807","volume":"4","author":"S Kroschwald","year":"2015","unstructured":"Kroschwald, S. et al. Promiscuous interactions and protein disaggregases determine the material state of stress-inducible RNP granules. Elife 4, e06807 (2015).","journal-title":"Elife"},{"key":"23974_CR38","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature04082","volume":"436","author":"JJ Feld","year":"2005","unstructured":"Feld, J. J. & Hoofnagle, J. H. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436, 967\u2013972 (2005).","journal-title":"Nature"},{"key":"23974_CR39","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"Fried, M. W. et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347, 975\u2013982 (2002).","journal-title":"N. Engl. J. Med."},{"key":"23974_CR40","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1016\/S0021-9258(17)42958-9","volume":"259","author":"MS Lui","year":"1984","unstructured":"Lui, M. S. et al. Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide). J. Biol. Chem. 259, 5078\u20135082 (1984).","journal-title":"J. Biol. Chem."},{"key":"23974_CR41","doi-asserted-by":"publisher","first-page":"18105","DOI":"10.1073\/pnas.0406927102","volume":"101","author":"A Kentsis","year":"2004","unstructured":"Kentsis, A., Topisirovic, I., Culjkovic, B., Shao, L. & Borden, K. L. Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap. Proc. Natl Acad. Sci. USA 101, 18105\u201318110 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"23974_CR42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2174\/092986730607220401123801","volume":"6","author":"P Franchetti","year":"1999","unstructured":"Franchetti, P. & Grifantini, M. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents. Curr. Med. Chem. 6, 599\u2013614 (1999).","journal-title":"Curr. Med. Chem."},{"key":"23974_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","volume":"98","author":"Z Wu","year":"1999","unstructured":"Wu, Z. et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115\u2013124 (1999).","journal-title":"Cell"},{"key":"23974_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5093","volume":"5","author":"D Duteil","year":"2014","unstructured":"Duteil, D. et al. LSD1 promotes oxidative metabolism of white adipose tissue. Nat. Commun. 5, 4093 (2014).","journal-title":"Nat. Commun."},{"key":"23974_CR45","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.15252\/embj.201591437","volume":"34","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. EglN2 associates with the NRF1-PGC1\u03b1 complex and controls mitochondrial function in breast cancer. EMBO J. 34, 2953\u20132970 (2015).","journal-title":"EMBO J."},{"key":"23974_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M Rojo de la Vega","year":"2018","unstructured":"Rojo de la Vega, M., Chapman, E. & Zhang, D. D. NRF2 and the hallmarks of cancer. Cancer Cell 34, 21\u201343 (2018).","journal-title":"Cancer Cell"},{"key":"23974_CR47","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMoa1603144","volume":"375","author":"CC Pritchard","year":"2016","unstructured":"Pritchard, C. C. et al. Inherited DNA-repair gene mutations in men with metastatic prostate cancer. N. Engl. J. Med. 375, 443\u2013453 (2016).","journal-title":"N. Engl. J. Med."},{"key":"23974_CR48","doi-asserted-by":"publisher","first-page":"eaam7479","DOI":"10.1126\/scisignal.aam7479","volume":"10","author":"L Li","year":"2017","unstructured":"Li, L. et al. Androgen receptor inhibitor-induced \u201cBRCAness\u201d and PARP inhibition are synthetically lethal for castration-resistant prostate cancer. Sci. Signal 10, eaam7479 (2017).","journal-title":"Sci. Signal"},{"key":"23974_CR49","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nrurol.2010.200","volume":"7","author":"L Richards","year":"2010","unstructured":"Richards, L. Prostate cancer: cabazitaxel boosts post-docetaxel survival. Nat. Rev. Urol. 7, 645 (2010).","journal-title":"Nat. Rev. Urol."},{"key":"23974_CR50","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1111\/cas.13729","volume":"109","author":"H Hongo","year":"2018","unstructured":"Hongo, H., Kosaka, T. & Oya, M. Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancer. Cancer Sci. 109, 2937\u20132945 (2018).","journal-title":"Cancer Sci."},{"key":"23974_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2015.12.008","volume":"51","author":"T Kosaka","year":"2016","unstructured":"Kosaka, T. et al. The prognostic significance of OCT4 expression in patients with prostate cancer. Hum. Pathol. 51, 1\u20138 (2016).","journal-title":"Hum. Pathol."},{"key":"23974_CR52","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nm.4045","volume":"22","author":"H Beltran","year":"2016","unstructured":"Beltran, H. et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat. Med. 22, 298\u2013305 (2016).","journal-title":"Nat. Med."},{"key":"23974_CR53","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson, D. et al. Integrative clinical genomics of advanced prostate cancer. Cell 161, 1215\u20131228 (2015).","journal-title":"Cell"},{"key":"23974_CR54","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida, W. et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc. Natl Acad. Sci. USA 116, 11428\u201311436 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"23974_CR55","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrurol.2017.65","volume":"14","author":"S Wang","year":"2017","unstructured":"Wang, S., Gao, D. & Chen, Y. The potential of organoids in urological cancer research. Nat. Rev. Urol. 14, 401\u2013414 (2017).","journal-title":"Nat. Rev. Urol."},{"key":"23974_CR56","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1210\/en.2019-00362","volume":"160","author":"S Shiba","year":"2019","unstructured":"Shiba, S. et al. Hormonal regulation of patient-derived endometrial cancer stem-like cells generated by three-dimensional culture. Endocrinology 160, 1895\u20131906 (2019).","journal-title":"Endocrinology"},{"key":"23974_CR57","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Lov\u00e9n","year":"2013","unstructured":"Lov\u00e9n, J. et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153, 320\u2013334 (2013).","journal-title":"Cell"},{"key":"23974_CR58","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cell.2015.08.063","volume":"163","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. CDK7-dependent transcriptional addiction in triple-negative breast cancer. Cell 163, 174\u2013186 (2015).","journal-title":"Cell"},{"key":"23974_CR59","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/emboj.2013.99","volume":"32","author":"K Takayama","year":"2013","unstructured":"Takayama, K. et al. Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer. EMBO J. 32, 1665\u20131680 (2013).","journal-title":"EMBO J."},{"key":"23974_CR60","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1073\/pnas.1721957115","volume":"115","author":"K Takayama","year":"2018","unstructured":"Takayama, K., Suzuki, T., Fujimura, T., Takahashi, S. & Inoue, S. COBLL1 modulates cell morphology and facilitates androgen receptor genomic binding in advanced prostate cancer. Proc. Natl Acad. Sci. USA 115, 4975\u20134980 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"23974_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"23974_CR62","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nm.3830","volume":"21","author":"R Malik","year":"2015","unstructured":"Malik, R. et al. Targeting the MLL complex in castration-resistant prostate cancer. Nat. Med. 21, 344\u2013352 (2015).","journal-title":"Nat. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23974-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23974-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23974-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T23:04:28Z","timestamp":1675465468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23974-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["23974"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-23974-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"30 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3766"}}